Lenox Wealth Management’s VanEck Biotech ETF BBH Stock Holding History

Lenox Wealth Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$24K	Buy	+153	New	+$23.3K	0.01%	331

Other funds holding BBH

PAG

Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Lenox Wealth Management's BBH Position: Q2 2020 in Review

Lenox Wealth Management opened a new position in VanEck Biotech ETF (BBH) in Q2 2020: 153 shares worth $24K. The stake represents 0.01% of the portfolio and ranks #331 among its holdings.

102 funds tracked by Wall St. Rank hold BBH as of Q2 2020.

Lenox Wealth Management held 153 shares of VanEck Biotech ETF worth $24K as of Q2 2020.
VanEck Biotech ETF was a new Lenox Wealth Management position in Q2 2020.
VanEck Biotech ETF made up 0.01% of Lenox Wealth Management's portfolio in Q2 2020, its #331 holding.
102 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.